[HTML][HTML] Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation
K Wang, X Wang, Q Pan, B Zhao - Molecular cancer, 2023 - Springer
Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a
potential curative approach for PC, but most patients are unsuitable for operations when at …
potential curative approach for PC, but most patients are unsuitable for operations when at …
[HTML][HTML] Treatment of dyslipidemia through targeted therapy of gut microbiota
B Flaig, R Garza, B Singh, S Hamamah, M Covasa - Nutrients, 2023 - mdpi.com
Dyslipidemia is a multifaceted condition with various genetic and environmental factors
contributing to its pathogenesis. Further, this condition represents an important risk factor for …
contributing to its pathogenesis. Further, this condition represents an important risk factor for …
[HTML][HTML] Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations
ZN Abbas, AZ Al-Saffar, SM Jasim, GM Sulaiman - Scientific Reports, 2023 - nature.com
Drug development is a time-consuming and expensive process, given the low success rate
of clinical trials. Now, anticancer drug developments have shifted to three-dimensional (3D) …
of clinical trials. Now, anticancer drug developments have shifted to three-dimensional (3D) …
[HTML][HTML] Recent trends in biosensing and diagnostic methods for novel cancer biomarkers
J Rao Bommi, S Kummari, K Lakavath, RA Sukumaran… - Biosensors, 2023 - mdpi.com
Cancer is one of the major public health issues in the world. It has become the second
leading cause of death, with approximately 75% of cancer deaths transpiring in low-or …
leading cause of death, with approximately 75% of cancer deaths transpiring in low-or …
Fungi and cancer
A Saftien, J Puschhof, E Elinav - Gut, 2023 - gut.bmj.com
The microbiome may impact cancer development, progression and treatment
responsiveness, but its fungal components remain insufficiently studied in this context. In this …
responsiveness, but its fungal components remain insufficiently studied in this context. In this …
[HTML][HTML] Interaction between microbiota and immunity and its implication in colorectal cancer
Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the world.
Besides genetic causes, colonic inflammation is one of the major risk factors for CRC …
Besides genetic causes, colonic inflammation is one of the major risk factors for CRC …
[HTML][HTML] Prognostic biomarkers of cell proliferation in colorectal cancer (CRC): from immunohistochemistry to molecular biology techniques
A Kasprzak - Cancers, 2023 - mdpi.com
Simple Summary This review aims to shed light on the proliferative markers important in the
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …
Integrated analysis of multi-omics data for the discovery of biomarkers and therapeutic targets for colorectal cancer
N Zafari, P Bathaei, M Velayati… - Computers in Biology …, 2023 - Elsevier
The considerable burden of colorectal cancer and the rising trend in young adults
emphasize the necessity of understanding its underlying mechanisms, providing new …
emphasize the necessity of understanding its underlying mechanisms, providing new …
Disease burden of total and early-onset colorectal cancer in China from 1990 to 2019 and predictions of cancer incidence and mortality
B Shao, M Zhu, K Shen, L Luo, P Du, J Li, J Xu… - Clinical …, 2023 - Taylor & Francis
Background Understanding the temporal trends in the epidemiology of colorectal cancer
(CRC) and early-onset CRC (EOCRC) in China is essential for policymakers to develop …
(CRC) and early-onset CRC (EOCRC) in China is essential for policymakers to develop …
[HTML][HTML] Application of polypyrrole-based electrochemical biosensor for the early diagnosis of colorectal cancer
Although colorectal cancer (CRC) is easy to treat surgically and can be combined with
postoperative chemotherapy, its five-year survival rate is still not optimistic. Therefore …
postoperative chemotherapy, its five-year survival rate is still not optimistic. Therefore …